We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

51 hedge funds and large institutions have $222M invested in Coherus Oncology in 2015 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

41% more capital invested

Capital invested by funds: $158M → $222M (+$64M)

34% more funds holding

Funds holding: 38 → 51 (+13)

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
51
Holders Change
+13
Holders Change %
+34.21%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
24
Increased
13
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$14.2M
2
Millennium Management
Millennium Management
New York
+$7.26M
3
CCI
Columbus Circle Investors
+$5.71M
4
HCMT
Highland Capital Management (Texas)
Texas
+$4.21M
5
EI
EAM Investors
California
+$4.2M

Top Sellers

Rank Fund Capital Flow
1
KKRC
Kohlberg Kravis Roberts & Co
New York
-$49.9M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$12.7M
3
PA
Perceptive Advisors
New York
-$9.12M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.09M
5
Morgan Stanley
Morgan Stanley
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
26
Mazama Capital Management
Oregon
$1.04M -$769K -29,768 -47%
Goldman Sachs
27
Goldman Sachs
New York
$710K +$600K +23,221 New
Charles Schwab
28
Charles Schwab
California
$590K +$140K +5,412 +39%
Citigroup
29
Citigroup
New York
$577K +$452K +17,500 +1,281%
Citadel Advisors
30
Citadel Advisors
Florida
$444K +$375K +14,510 New
SAM
31
Sectoral Asset Management
Quebec, Canada
$387K +$327K +12,656 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$379K -$7.75K -300 -2%
MLL
33
Moody Lynn & Lieberson
Massachusetts
$338K +$285K +11,040 New
GGHC
34
Gilder Gagnon Howe & Co
New York
$315K +$266K +10,304 New
BC
35
Birchview Capital
Vermont
$229K +$194K +7,500 New
CIM
36
CIM Investment Management
Pennsylvania
$223K +$188K +7,277 New
AllianceBernstein
37
AllianceBernstein
Tennessee
$199K +$168K +6,500 New
TA
38
Teachers Advisors
New York
$198K +$5.56K +215 +3%
GC
39
Globeflex Capital
California
$187K +$158K +6,121 New
NFA
40
Nationwide Fund Advisors
Ohio
$153K +$5.92K +229 +5%
AIG
41
American International Group
New York
$131K – – –
UBS Group
42
UBS Group
Switzerland
$78K +$48.2K +1,866 +272%
Morgan Stanley
43
Morgan Stanley
New York
$30K -$1.49M -57,806 -98%
PCM
44
Prelude Capital Management
New York
$21K -$20.7K -800 -53%
BRWM
45
B. Riley Wealth Management
Tennessee
$13K +$11.2K +434 New
Wells Fargo
46
Wells Fargo
California
$10K +$8.76K +339 New
Barclays
47
Barclays
United Kingdom
$7K -$4.65K -180 -46%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$4.62K +$3.9K +151 New
Bank of America
49
Bank of America
North Carolina
$1K +$465 +18 New
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$136 +$115K +4,452 New
1
2
3

CHRS Hedge Fund Activity: Q1 2015 in Review

51 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2015, worth a combined $222M — up 41% from $158M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CHRS positions and 11 closed out — a net gain of 13 holders — while 13 added to existing stakes and 11 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $14.2M. The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $49.9M sold.

  • 51 institutional investors held Coherus Oncology (CHRS) as of Q1 2015, up from 38 in Q4 2014.
  • Funds reported $222M of Coherus Oncology stock for Q1 2015, up 41% quarter-over-quarter.
  • 24 funds opened new Coherus Oncology positions in Q1 2015 and 11 closed out, a net change of +13 holders.
  • The largest Coherus Oncology buyer in Q1 2015 was JP Morgan Chase, an estimated $14.2M added.
  • The largest Coherus Oncology seller in Q1 2015 was Kohlberg Kravis Roberts & Co, an estimated $49.9M sold.

Based on aggregated 13F filings for Q1 2015.